Literature DB >> 9690757

Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy.

D Guidetti1, R Sabadini, M Bondavalli, S Cavalletti, M Lodesani, R Mantegazza, V Cosi, F Solime.   

Abstract

We carried out a retrospective incidence, prevalence and mortality survey of myasthenia gravis in the province of Reggio Emilia in Northern Italy. Based on 49 patients, the mean incidence per year for the period 1980 through 1994 was 7.8 per 1,000,000. On 31 December 1994 the prevalence rate was 117.5 per 1,000,000 for all patients, either active or recovered (50 cases in a population of 427,493) and 103.4 per 1,000,000 for the active disease. In the 15-year period 1980-1994 the average mortality rate was 1.0 per 1,000,000 per year. The average age at onset was 44.6 +/- 21.0, and the average age at the time of prevalence determination was 51.1 +/- 19.6 for the active disease. At the time of diagnosis, 21 patients (36.8%) were classed in group I according to Osserman's criteria, 31 in group II (54.4%), (19 in group II-A and 12 in group II-B), and the other 5 (8.8%) in group III. Of all the prevalence cases, 6 (12%) were in remission without therapy and 6 with therapy, while most of the others 16 (32%) were classed in group I, 15 (30%) in group II, and 1 (2%) in group III. Thymectomy was performed in 20 patients (35.1%), 12 (21%) had thymoma (malignant in 4 cases), 6 had thymic hyperplasia while in two patients thymic histology was normal. The relation the grade of Osserman's scale at the time of incidence and the presence of thymoma were significant. Higher grades of Osserman's scale were associated were malignant thymoma. Furthermore the relationship between thymectomy and the grade of Osserman's scale at the date of prevalence was significant for the presence of lower grades of Osserman's scale in the patients submitted to thymectomy.

Entities:  

Mesh:

Year:  1998        PMID: 9690757     DOI: 10.1023/a:1007449221638

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  17 in total

1.  Epidemiology of myasthenia gravis in the province of Trento (northern Italy).

Authors:  G Ferrari; M G Lovaste
Journal:  Neuroepidemiology       Date:  1992       Impact factor: 3.282

Review 2.  Humoral pathogenesis of myasthenia gravis.

Authors:  D B Drachman; S de Silva; D Ramsay; A Pestronk
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

Review 3.  Epidemiology of myasthenia gravis.

Authors:  J F Kurtzke
Journal:  Adv Neurol       Date:  1978

4.  Reliable disability scale for myasthenia gravis sensitive to clinical changes.

Authors:  R D'Alessandro; M Casmiro; G Benassi; R Rinaldi; G Gamberini
Journal:  Acta Neurol Scand       Date:  1995-07       Impact factor: 3.209

5.  Epidemiological survey of multiple sclerosis in the provinces of Reggio Emilia and Modena, Italy.

Authors:  D Guidetti; S Cavalletti; E Merelli; P Zanoni; P Simonazzi; P Sola; F Solimé
Journal:  Neuroepidemiology       Date:  1995       Impact factor: 3.282

Review 6.  Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients.

Authors:  K E Osserman; G Genkins
Journal:  Mt Sinai J Med       Date:  1971 Nov-Dec

7.  Myasthenia gravis in the county of Viborg, Denmark.

Authors:  T T Sørensen; E B Holm
Journal:  Eur Neurol       Date:  1989       Impact factor: 1.710

8.  Epidemiological study of myasthenia gravis in Sardinia, Italy (1958-1986).

Authors:  M Giagheddu; G Puggioni; G Sanna; G Tamburini; F Marrosu; M G Rachele; B Murgia; G Rosati
Journal:  Acta Neurol Scand       Date:  1989-04       Impact factor: 3.209

9.  Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey.

Authors:  F E Somnier; N Keiding; O B Paulson
Journal:  Arch Neurol       Date:  1991-07

10.  The natural course of myasthenia gravis: a long term follow up study.

Authors:  H J Oosterhuis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-10       Impact factor: 10.154

View more
  4 in total

1.  Clinical features of myasthenia gravis in southern China: a retrospective review of 2,154 cases over 22 years.

Authors:  X Huang; W B Liu; L N Men; H Y Feng; Y Li; C M Luo; L Qiu
Journal:  Neurol Sci       Date:  2012-07-18       Impact factor: 3.307

Review 2.  A systematic review of population based epidemiological studies in Myasthenia Gravis.

Authors:  Aisling S Carr; Chris R Cardwell; Peter O McCarron; John McConville
Journal:  BMC Neurol       Date:  2010-06-18       Impact factor: 2.474

3.  Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis.

Authors:  Nader Salari; Behnaz Fatahi; Yalda Bartina; Mohsen Kazeminia; Reza Fatahian; Payam Mohammadi; Shamarina Shohaimi; Masoud Mohammadi
Journal:  J Transl Med       Date:  2021-12-20       Impact factor: 5.531

4.  Incidence of thymoma in myasthenia gravis: a systematic review.

Authors:  Zhi-Feng Mao; Xue-An Mo; Chao Qin; Yong-Rong Lai; Maree L Hackett
Journal:  J Clin Neurol       Date:  2012-09-27       Impact factor: 3.077

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.